Study of experimental gel for actinic keratosis on the face
Part of Cancer, Skin clinical trials.
This trial tests an investigational gel called HW211026 for people with actinic keratosis, a common precancerous skin condition. It aims to see if the gel is a safe and effective treatment for lesions on the face.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need 2 to 8 typical actinic keratosis spots on your face (these are rough, scaly patches caused by sun damage).
- You must agree to avoid direct sunlight or UV exposure to your face during the study.
- You cannot have any other skin cancers or suspicious growths near the treated spots.
- You should not have had major surgery in the past 3 months or plan to have surgery during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a reformulated light-activated cream (Levulan Kerastick) for treating actinic keratosis (precancerous skin spots) on the face or bald scalp. It is a phase 3 study to see if the new version works better with fewer side effects.
This trial tests a new gel and light treatment for actinic keratosis (rough, sun-damaged spots) on the arm. It aims to see if it can safely remove these spots and prevent new ones.
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
This study tests a new gel called VC005 to see if it safely reduces itching, redness, and irritation in people with atopic dermatitis (a chronic skin condition). You'll be randomly assigned to either the new gel or a placebo (inactive gel) and apply it to affected areas over several weeks.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
This study tests a herbal ointment (Veregen) for actinic keratosis, a common precancerous skin condition. The ointment is applied to the face or bald scalp. It may offer a new treatment option for mild to moderate spots.
Hear when a new Actinic Keratosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.